Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million with contributions from new and existing investors. The Cresskill, N.J.–based clinical-stage biopharma company originally targeted $15 million for the financing, but finished with a total of $17.3 million raised. Get the full story at our sister site, MassDevice.
ASLS wins Frost & Sullivan bioprinting award
Advanced Solutions Life Sciences announced that it won the Frost & Sullivan 2019 Bioprinting Value Leadership Award for demonstrating best-in-class biofabrication, hardware, software and consulting services. Last month’s award highlights global consultancy firm Frost & Sullivan’s view that ASLS develops unique and cost-effective solutions to advance the development of life-saving drugs by way of 3D bioprinting,…
Dyve Biosciences hires new chief scientific officer
Transdermal drug therapy developer Dyve Biosciences announced that it appointed longtime Pfizer executive Chuck Harbert to the role of chief scientific officer. Harbert spent three decades at Pfizer, serving as the company’s VP of U.S. exploratory development and strategic planning, among other senior positions with Pfizer Central Research. He is the inventor and co-inventor of 35 pharmaceutical…
Drug or device? FDA loses this argument for now
This article has been updated with comments from an attorney for Genus Medical Technologies. A federal judge has temporarily blocked an attempt by the FDA to regulate a barium sulfate product ingested before imaging as a drug. The decision counts as at least a partial win for Genus Medical Technologies (St. Louis), maker of the Vanilla SilQ line of…
Propeller Health offers access to CVS, other pharmacies with Propeller app
Propeller Health announced today that users of its Propeller app are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly through that app. The Madison, Wis.–based company launched the app in January 2019, giving Walgreens patients the option to manage their asthma or chronic obstructive pulmonary disease medication regimen within the mobile app.…